RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID

RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID

Show other versions (1)

Aim. To evaluate risk of repeated atherothrombotic events in patients survived acute coronary syndrome (ACS) and having poorly reduced platelet aggregation (proven by optical aggregometry) in response to acetylsalicylic acid (ASA) therapy.Material and methods. 200 patients with ACS (aged 56,6±9,2 y....

Full description

Bibliographic Details
Main Authors: N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky
Format: Article
Language:English
Published: Столичная издательская компания 2016-01-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
acute coronary syndrome
antiaggregants
therapy efficacy
cardiovascular сomplications
Online Access:https://www.rpcardio.online/jour/article/view/734

Internet

https://www.rpcardio.online/jour/article/view/734

Similar Items